# Gilead Sciences (GILD) SEC filings: 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/GILD/filings

> Gilead Sciences (GILD) SEC filings from EDGAR: 10-K filed Feb 24, 2026, 10-Q filed Oct 30, 2026, 8-K filed Oct 29, 2026. 173 filings in the last 12 months.

---

## Gilead Sciences (GILD) SEC filings

Gilead Sciences's latest annual report is a Form 10-K filed on February 24, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on October 30, 2026. Its latest current report, a Form 8-K, was filed on October 29, 2026 (2.02 Results of Operations and Financial Condition).

### Key facts

- **Latest annual report:** 10-K, Feb 24, 2026
- **Latest quarterly report:** 10-Q, Oct 30, 2026
- **Latest 8-K:** 8-K, Oct 29, 2026
- **Filings, last 12 months:** 173
- **Insider forms, last 12 months:** 87 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 10
- **SEC central index key:** 0000882095

Filings as listed by SEC EDGAR at Nov 18, 2026, 12:10 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000882095](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882095). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Gilead Sciences: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/gild-20260930.htm) | Oct 30, 2026 | Sep 30, 2026 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm) | Aug 6, 2026 | Jun 30, 2026 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000024/gild-20260331.htm) | May 7, 2026 | Mar 31, 2026 | FORM 10-Q |
| [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm) | Feb 24, 2026 | Dec 31, 2025 | FORM 10-K |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/gild-20250930.htm) | Nov 7, 2025 | Sep 30, 2025 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000032/gild-20250630.htm) | Aug 7, 2025 | Jun 30, 2025 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000012/gild-20250331.htm) | May 7, 2025 | Mar 31, 2025 | FORM 10-Q |
| [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/gild-20241231.htm) | Feb 28, 2025 | Dec 31, 2024 | FORM 10-K |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209524000028/gild-20240930.htm) | Nov 12, 2024 | Sep 30, 2024 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209524000022/gild-20240630.htm) | Aug 8, 2024 | Jun 30, 2024 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209524000013/gild-20240331.htm) | May 8, 2024 | Mar 31, 2024 | FORM 10-Q |
| [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/gild-20231231.htm) | Feb 23, 2024 | Dec 31, 2023 | FORM 10-K |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209523000031/gild-20230930.htm) | Nov 7, 2023 | Sep 30, 2023 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209523000025/gild-20230630.htm) | Aug 4, 2023 | Jun 30, 2023 | FORM 10-Q |
| [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209523000017/gild-20230331.htm) | May 3, 2023 | Mar 31, 2023 | FORM 10-Q |
| [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209523000007/gild-20221231.htm) | Feb 22, 2023 | Dec 31, 2022 | FORM 10-K |

The latest 16 of 36 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

Gilead Sciences: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000037/gild-20261029.htm) | Oct 29, 2026 | Oct 29, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000028/gild-20260804.htm) | Aug 4, 2026 | Aug 4, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465926064518/tm2615045d1_8k.htm) | May 20, 2026 | May 14, 2026 | 1.01 Entry into a Material Definitive Agreement 2.03 Creation of a Direct Financial Obligation 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000022/gild-20260507.htm) | May 7, 2026 | May 7, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/gild-20260430.htm) | May 4, 2026 | Apr 30, 2026 | 5.07 Submission of Matters to a Vote of Security Holders 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465926049874/tm2612748d1_8k.htm) | Apr 28, 2026 | Apr 28, 2026 | 7.01 Regulation FD Disclosure 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465926018314/tm267044d1_8k.htm) | Feb 23, 2026 | Feb 22, 2026 | 1.01 Entry into a Material Definitive Agreement 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000003/gild-20260210.htm) | Feb 10, 2026 | Feb 10, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465925113968/tm2531634d1_8k.htm) | Nov 19, 2025 | Nov 15, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000044/gild-20251030.htm) | Oct 30, 2025 | Oct 30, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000041/gild-20251006.htm) | Oct 6, 2025 | Oct 6, 2025 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000035/gild-20250810.htm) | Aug 14, 2025 | Aug 10, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000030/gild-20250807.htm) | Aug 7, 2025 | Aug 7, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000022/gild-20250730.htm) | Aug 4, 2025 | Jul 30, 2025 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000015/gild-20250507.htm) | May 8, 2025 | May 7, 2025 | 5.07 Submission of Matters to a Vote of Security Holders 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000009/gild-20250424.htm) | Apr 24, 2025 | Apr 24, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465925023012/tm258955d1_8k.htm) | Mar 12, 2025 | Mar 9, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000003/gild-20250211.htm) | Feb 11, 2025 | Feb 11, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465924128088/tm2430889d1_8ka.htm) | Dec 13, 2024 | Jul 17, 2024 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465924121025/tm2426602d4_8k.htm) | Nov 20, 2024 | Nov 20, 2024 | 1.01 Entry into a Material Definitive Agreement 2.03 Creation of a Direct Financial Obligation 8.01 Other Events 9.01 Financial Statements and Exhibits |

The latest 20 of 90 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

Gilead Sciences: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 6 |
| Oct 2026 | 3 |
| Sep 2026 | 9 |
| Aug 2026 | 6 |
| Jul 2026 | 3 |
| Jun 2026 | 8 |
| May 2026 | 11 |
| Apr 2026 | 3 |
| Mar 2026 | 14 |
| Feb 2026 | 8 |
| Jan 2026 | 6 |
| Dec 2025 | 10 |

Gilead Sciences: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000178213526000037/xslF345X06/wk-form4_1794965557.xml) | Nov 17, 2026 | Nov 16, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000131020426000033/xslF345X06/wk-form4_1794965360.xml) | Nov 17, 2026 | Nov 16, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000162988526000008/xslF345X06/wk-form4_1794861125.xml) | Nov 16, 2026 | Nov 12, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000211060326000015/xslF345X06/wk-form4_1794270020.xml) | Nov 9, 2026 | Nov 6, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000163864326000040/xslF345X06/wk-form4_1794003356.xml) | Nov 6, 2026 | Nov 4, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000163864326000038/xslF345X06/wk-form4_1793664889.xml) | Nov 2, 2026 | Oct 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000131020426000031/xslF345X06/wk-form4_1792181840.xml) | Oct 16, 2026 | Oct 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000178213526000035/xslF345X06/wk-form4_1792181553.xml) | Oct 16, 2026 | Oct 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000163864326000035/xslF345X06/wk-form4_1790973619.xml) | Oct 2, 2026 | Oct 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000192764826000005/xslF345X06/wk-form4_1790194631.xml) | Sep 23, 2026 | Sep 22, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000131020426000029/xslF345X06/wk-form4_1789590643.xml) | Sep 16, 2026 | Sep 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000178213526000033/xslF345X06/wk-form4_1789590469.xml) | Sep 16, 2026 | Sep 15, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000131020426000027/xslF345X06/wk-form4_1789165843.xml) | Sep 11, 2026 | Sep 10, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000173951526000011/xslF345X06/wk-form4_1789165789.xml) | Sep 11, 2026 | Sep 10, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000178213526000031/xslF345X06/wk-form4_1789165734.xml) | Sep 11, 2026 | Sep 10, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000211060326000013/xslF345X06/wk-form4_1789165685.xml) | Sep 11, 2026 | Sep 10, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000163864326000033/xslF345X06/wk-form4_1789165629.xml) | Sep 11, 2026 | Sep 10, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000163864326000031/xslF345X06/wk-form4_1788379963.xml) | Sep 2, 2026 | Sep 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/xslF345X06/wk-form4_1787870685.xml) | Aug 27, 2026 | Aug 26, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/xslF345X06/wk-form4_1787354535.xml) | Aug 21, 2026 | Aug 20, 2026 |

The latest 20 of 583 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

Gilead Sciences: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/882095/000112329226001496/xslSCHEDULE_13G_X02/primary_doc.xml) | Nov 6, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465926092737/xslSCHEDULE_13D_X02/primary_doc.xml) | Aug 7, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329226000750/xslSCHEDULE_13D_X02/primary_doc.xml) | May 27, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/882095/000210011926000510/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 29, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465926049902/xslSCHEDULE_13D_X02/primary_doc.xml) | Apr 28, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000010290926001398/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 26, 2026 | — |
| [Schedule 13D](https://www.sec.gov/Archives/edgar/data/882095/000090445426000123/xslSCHEDULE_13D_X01/primary_doc.xml) | Feb 23, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329226000166/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 12, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329226000163/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 12, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/882095/000031506626000432/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 5, 2026 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000613/xslSCHEDULE_13D_X01/primary_doc.xml) | Nov 5, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000366/xslSCHEDULE_13G_X01/primary_doc.xml) | Aug 14, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000353/xslSCHEDULE_13D_X01/primary_doc.xml) | Aug 12, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000309/xslSCHEDULE_13D_X01/primary_doc.xml) | Jul 15, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000142284825000119/xslSCHEDULE_13G_X01/primary_doc.xml) | May 13, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000205211325001603/xslSCHEDULE_13G_X01/primary_doc.xml) | Apr 24, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000148/xslSCHEDULE_13G_X01/primary_doc.xml) | Mar 20, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000115/xslSCHEDULE_13D_X01/primary_doc.xml) | Mar 5, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000105/xslSCHEDULE_13D_X01/primary_doc.xml) | Feb 20, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/882095/000112329225000081/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 13, 2025 | — |

The latest 20 of 78 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

Gilead Sciences: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000130817926000107/gild014721-defa14a.htm) | Mar 20, 2026 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000130817926000106/gild014721-def14a.htm) | Mar 20, 2026 | Apr 30, 2026 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000130817925000253/gild013520-defa14a.htm) | Mar 27, 2025 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000130817925000252/gild013520-def14a.htm) | Mar 27, 2025 | May 7, 2025 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000130817924000349/lgild2024_defa14a.htm) | Mar 28, 2024 | — | GILEAD SCIENCES, INC. - DEFA14A |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000130817924000348/lgild2024_def14a.htm) | Mar 28, 2024 | May 8, 2024 | GILEAD SCIENCES, INC. - DEF 14A |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/882095/000130817924000190/lgild2024_pre14a.htm) | Mar 18, 2024 | May 8, 2024 | GILEAD SCIENCES, INC. - PRE 14A |
| [DEFR14A](https://www.sec.gov/Archives/edgar/data/882095/000110465923042138/tm2311889d1_defr14a.htm) | Apr 5, 2023 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000130817923000323/gild4141721-def14a.htm) | Mar 23, 2023 | — | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000130817923000324/gild4141721-defa14a.htm) | Mar 23, 2023 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000120677422000833/gild3988061-defa14a.htm) | Mar 24, 2022 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000120677422000832/gild3988061-def14a.htm) | Mar 24, 2022 | May 4, 2022 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000120677421000909/gild3818501-defa14a.htm) | Mar 30, 2021 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000120677421000908/gild3818501-def14a.htm) | Mar 30, 2021 | May 12, 2021 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000110465920047020/tm2015589-1_defa14a.htm) | Apr 15, 2020 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000120677420000887/gild3646261-defa14a.htm) | Mar 24, 2020 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000120677420000886/gild3646261-def14a.htm) | Mar 24, 2020 | May 6, 2020 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/882095/000120677419001014/gild3496971-defa14a.htm) | Mar 25, 2019 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/882095/000120677419001013/gild3496971-def14a.htm) | Mar 25, 2019 | May 8, 2019 | DEFINITIVE PROXY STATEMENT |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/882095/000120677419000875/gild3496971-pre14a.htm) | Mar 15, 2019 | May 8, 2019 | PRELIMINARY PROXY STATEMENT |

**Everything else (193 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Gilead Sciences: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726011134/xsl144X01/primary_doc.xml) | Nov 16, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726011121/xsl144X01/primary_doc.xml) | Nov 16, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726011039/xsl144X01/primary_doc.xml) | Nov 12, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726010782/xsl144X01/primary_doc.xml) | Nov 6, 2026 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/882095/000112329226001479/xslForm13F_X02/primary_doc.xml) | Nov 6, 2026 | Sep 30, 2026 |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726010699/xsl144X01/primary_doc.xml) | Nov 4, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726010512/xsl144X01/primary_doc.xml) | Oct 30, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726010250/xsl144X01/primary_doc.xml) | Oct 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726010246/xsl144X01/primary_doc.xml) | Oct 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726009482/xsl144X01/primary_doc.xml) | Sep 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726009467/xsl144X01/primary_doc.xml) | Sep 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726008716/xsl144X01/primary_doc.xml) | Aug 26, 2026 | — | Notice of proposed sale |
| [N-PX](https://www.sec.gov/Archives/edgar/data/882095/000112329226001172/xslN-PX_X01/primary_doc.xml) | Aug 26, 2026 | Jun 30, 2026 |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726008471/xsl144X01/primary_doc.xml) | Aug 20, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726008219/xsl144X01/primary_doc.xml) | Aug 17, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726008208/xsl144X01/primary_doc.xml) | Aug 17, 2026 | — | Notice of proposed sale |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/882095/000110465926092110/tm2621295-1_s3asr.htm) | Aug 6, 2026 | — | Short-form registration statement |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726007556/xsl144X01/primary_doc.xml) | Aug 3, 2026 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/882095/000112329226001034/xslForm13F_X02/primary_doc.xml) | Aug 3, 2026 | Jun 30, 2026 |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726007094/xsl144X01/primary_doc.xml) | Jul 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726007091/xsl144X01/primary_doc.xml) | Jul 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726006086/xsl144X01/primary_doc.xml) | Jun 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726006066/xsl144X01/primary_doc.xml) | Jun 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726005428/xsl144X01/primary_doc.xml) | Jun 1, 2026 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/882095/000110465926063199/tm2531124-2_424b5.htm) | May 18, 2026 | — | Prospectus |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726004585/xsl144X01/primary_doc.xml) | May 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726004577/xsl144X01/primary_doc.xml) | May 15, 2026 | — | Notice of proposed sale |
| [FWP](https://www.sec.gov/Archives/edgar/data/882095/000110465926061317/tm2531124d3_fwp.htm) | May 14, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/882095/000110465926060745/tm2531124-1_424b5.htm) | May 14, 2026 | — | Prospectus |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/882095/000112329226000642/xslForm13F_X02/primary_doc.xml) | May 8, 2026 | Mar 31, 2026 |  |
| [S-8](https://www.sec.gov/Archives/edgar/data/882095/000088209526000025/forms-8amendedequityincent.htm) | May 7, 2026 | — | FORM S-8 |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726003805/xsl144X01/primary_doc.xml) | Apr 28, 2026 | — | Notice of proposed sale |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465926049870/tm2612748d3_sctota.htm) | Apr 28, 2026 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465926044653/tm2612074d1_sctota.htm) | Apr 17, 2026 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726003475/xsl144X01/primary_doc.xml) | Apr 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726003472/xsl144X01/primary_doc.xml) | Apr 15, 2026 | — | Notice of proposed sale |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/882095/000110465926038557/tm2610852d1_sctota.htm) | Apr 1, 2026 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726003040/xsl144X01/primary_doc.xml) | Mar 27, 2026 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/882095/000130817926000108/gild014721-ars.pdf) | Mar 20, 2026 | Dec 31, 2025 | ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726002618/xsl144X01/primary_doc.xml) | Mar 16, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726002616/xsl144X01/primary_doc.xml) | Mar 16, 2026 | — | Notice of proposed sale |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/882095/000110465926024755/tm267838-1_sctot.htm) | Mar 6, 2026 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726001875/xsl144X01/primary_doc.xml) | Feb 27, 2026 | — | Notice of proposed sale |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/882095/000110465926018531/tm267075d1_sctoc.htm) | Feb 23, 2026 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/882095/000110465926018316/tm267044d1_8k.htm) | Feb 23, 2026 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726001310/xsl144X01/primary_doc.xml) | Feb 17, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726001306/xsl144X01/primary_doc.xml) | Feb 17, 2026 | — | Notice of proposed sale |
| [13F-HR](https://www.sec.gov/Archives/edgar/data/882095/000112329226000164/xslForm13F_X02/primary_doc.xml) | Feb 12, 2026 | Dec 31, 2025 |  |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000951/xsl144X01/primary_doc.xml) | Feb 5, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000737/xsl144X01/primary_doc.xml) | Jan 28, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000651/xsl144X01/primary_doc.xml) | Jan 23, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000633/xsl144X01/primary_doc.xml) | Jan 22, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000535/xsl144X01/primary_doc.xml) | Jan 20, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000432/xsl144X01/primary_doc.xml) | Jan 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004726000429/xsl144X01/primary_doc.xml) | Jan 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004725010726/xsl144X01/primary_doc.xml) | Dec 29, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004725010274/xsl144X01/primary_doc.xml) | Dec 15, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004725010272/xsl144X01/primary_doc.xml) | Dec 15, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004725009461/xsl144X01/primary_doc.xml) | Nov 28, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/882095/000195004725009457/xsl144X01/primary_doc.xml) | Nov 28, 2025 | — | Notice of proposed sale |

The latest 60 of 193 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13D — Schedule 13D beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form PRE 14A — Preliminary proxy statement**

A preliminary proxy statement subject to review by the SEC staff.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Gilead Sciences's latest annual report (10-K)?**

Gilead Sciences filed its latest Form 10-K with the SEC on February 24, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did Gilead Sciences file its latest 10-Q?**

On October 30, 2026 for the period ended September 30, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has Gilead Sciences reported on Form 8-K recently?**

Its latest 8-K was filed on October 29, 2026 (2.02 Results of Operations and Financial Condition). In the last twelve months the items it reported most often were: 2.02 Results of Operations and Financial Condition (4 reports); 1.01 Entry into a Material Definitive Agreement (2 reports); 7.01 Regulation FD Disclosure (2 reports). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for GILD in the last year?**

87 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 17, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Gilead Sciences?**

EDGAR lists 10 Schedule 13D or 13G filings about Gilead Sciences in the last twelve months, the latest on November 6, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Gilead Sciences (GILD) SEC filings: 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
